Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

If you have MS, your immune system attacks the myelin sheath that insulates your neurons. This is called demyelination. Demyelination makes it more difficult for electrical signals to travel ...

Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...

Developed under an exclusive worldwide licence agreement with UCB, PTD802 is designed to counteract the effects of ...

Demyelination in MS occurs when the immune system attacks and damages the myelin sheaths that insulate and nourish axons and nerve fibres in the central nervous system, leading to multifocal ...

Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from the UK’s MHRA for its lead candidate, PTD802.